Tectonic Therapeutic (TECX) News Today $22.38 +2.84 (+14.53%) As of 04/24/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Analysts Set Tectonic Therapeutic (NASDAQ:TECX) Target Price at $77.75April 24 at 2:41 AM | americanbankingnews.comTectonic Therapeutic (NASDAQ:TECX) Coverage Initiated by Analysts at MizuhoMizuho started coverage on Tectonic Therapeutic in a research note on Monday. They issued an "outperform" rating and a $51.00 price target on the stock.April 23 at 8:11 AM | marketbeat.comTectonic Therapeutic: A Buy On Massive Opportunity Of TX45 In PH HFpEFApril 23 at 6:04 AM | seekingalpha.comTectonic Therapeutic (NASDAQ:TECX) Short Interest UpdateTectonic Therapeutic (NASDAQ:TECX - Get Free Report) saw a large increase in short interest in the month of March. As of March 31st, there was short interest totalling 1,100,000 shares, an increase of 24.7% from the March 15th total of 882,400 shares. Based on an average daily volume of 350,300 shares, the short-interest ratio is presently 3.1 days. Approximately 10.3% of the company's shares are sold short.April 22 at 6:28 AM | marketbeat.comTectonic Therapeutic (NASDAQ:TECX) Earns Outperform Rating from Analysts at MizuhoApril 22 at 3:55 AM | americanbankingnews.comTectonic Therapeutic initiated with an Outperform at MizuhoApril 21, 2025 | markets.businessinsider.comMizuho Initiates Coverage of Tectonic Therapeutic (TECX) with Outperform RecommendationApril 21, 2025 | msn.comTectonic Therapeutic (NASDAQ:TECX) Receives Average Rating of "Buy" from BrokeragesTectonic Therapeutic (NASDAQ:TECX - Get Free Report) has been given an average recommendation of "Buy" by the six brokerages that are presently covering the firm, Marketbeat Ratings reports. Five research analysts have rated the stock with a buy recommendation and one has issued a strong buy recoApril 21, 2025 | marketbeat.comTectonic Therapeutic (TECX) Receives Outperform Rating from Mizuho | TECX Stock NewsApril 21, 2025 | gurufocus.comVanguard Group Inc. Has $16.67 Million Position in Tectonic Therapeutic (NASDAQ:TECX)Vanguard Group Inc. cut its holdings in Tectonic Therapeutic (NASDAQ:TECX - Free Report) by 18.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 361,048 shares of the company's stock after selling 81,766 shares duriApril 19, 2025 | marketbeat.comTectonic Therapeutic to Present Phase 1b Data for TX45 at European Society of Cardiology Heart Failure 2025April 15, 2025 | markets.businessinsider.comTectonic Therapeutic (NASDAQ:TECX) Director Acquires $54,877.68 in StockApril 12, 2025 | insidertrades.comTectonic Therapeutic (NASDAQ:TECX) Director Acquires $1,496,250.00 in StockApril 10, 2025 | insidertrades.comTectonic Therapeutic (NASDAQ:TECX) Shares Sold by ADAR1 Capital Management LLCADAR1 Capital Management LLC trimmed its holdings in Tectonic Therapeutic (NASDAQ:TECX - Free Report) by 53.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 58,708 shares of the company's stock after selling 68,451 sApril 9, 2025 | marketbeat.comTectonic Therapeutic files to sell 3.69M shares of common stock for holdersMarch 27, 2025 | markets.businessinsider.comTectonic Therapeutic (NASDAQ:TECX) Given Consensus Recommendation of "Buy" by BrokeragesShares of Tectonic Therapeutic (NASDAQ:TECX - Get Free Report) have earned an average recommendation of "Buy" from the six research firms that are presently covering the company, Marketbeat.com reports. Five research analysts have rated the stock with a buy rating and one has assigned a strong buMarch 25, 2025 | marketbeat.comWells Fargo & Company Has Lowered Expectations for Tectonic Therapeutic (NASDAQ:TECX) Stock PriceWells Fargo & Company cut their price objective on Tectonic Therapeutic from $112.00 to $101.00 and set an "overweight" rating for the company in a report on Friday.March 22, 2025 | marketbeat.comTectonic Therapeutic (NASDAQ:TECX) Releases Quarterly Earnings Results, Beats Expectations By $0.08 EPSTectonic Therapeutic (NASDAQ:TECX - Get Free Report) released its quarterly earnings data on Thursday. The company reported ($0.84) EPS for the quarter, topping analysts' consensus estimates of ($0.92) by $0.08.March 21, 2025 | marketbeat.comTectonic Therapeutic Inc (TECX) Reports Q4 2024 Net Loss of $12. ...March 20, 2025 | gurufocus.comTectonic Therapeutic Announces Fourth Quarter and Full Year 2024 Financial Results and Recent ...March 20, 2025 | gurufocus.comTectonic Therapeutic Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Business HighlightsMarch 20, 2025 | globenewswire.comTectonic Therapeutic (NASDAQ:TECX) Stake Trimmed by Atlas Venture Life Science Advisors LLCAtlas Venture Life Science Advisors LLC cut its position in shares of Tectonic Therapeutic (NASDAQ:TECX - Free Report) by 79.3% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 78,447 shares of the company'March 7, 2025 | marketbeat.comTectonic Therapeutic (NASDAQ:TECX) Sees Significant Decrease in Short InterestTectonic Therapeutic (NASDAQ:TECX - Get Free Report) was the target of a large decrease in short interest during the month of February. As of February 15th, there was short interest totalling 888,500 shares, a decrease of 16.2% from the January 31st total of 1,060,000 shares. Based on an average trading volume of 284,700 shares, the short-interest ratio is currently 3.1 days. Currently, 10.3% of the shares of the company are sold short.March 6, 2025 | marketbeat.comTectonic Therapeutic (TECX) Expected to Announce Quarterly Earnings on ThursdayTectonic Therapeutic (NASDAQ:TECX) will be releasing earnings before the market opens on Thursday, March 13, Financial Modeling Prep reports.March 6, 2025 | marketbeat.comTectonic Therapeutic (NASDAQ:TECX) Given Consensus Rating of "Buy" by BrokeragesTectonic Therapeutic (NASDAQ:TECX - Get Free Report) has been given an average rating of "Buy" by the six brokerages that are currently covering the stock, MarketBeat reports. Five equities research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendaFebruary 28, 2025 | marketbeat.comTectonic Therapeutic, Inc. (TECX): Among the Most Expensive Stocks Insiders Are Buying RecentlyFebruary 22, 2025 | msn.comTectonic Therapeutic to Participate in March Investor ConferencesFebruary 20, 2025 | markets.businessinsider.comTectonic Therapeutic (NASDAQ:TECX) Sees Significant Growth in Short InterestTectonic Therapeutic (NASDAQ:TECX - Get Free Report) was the target of a large increase in short interest in the month of January. As of January 31st, there was short interest totalling 1,060,000 shares, an increase of 60.3% from the January 15th total of 661,100 shares. Based on an average daily volume of 260,900 shares, the short-interest ratio is currently 4.1 days. Currently, 13.8% of the shares of the company are short sold.February 13, 2025 | marketbeat.comDeep Track Capital, LP Acquires Significant Stake in Tectonic Therapeutic IncFebruary 10, 2025 | gurufocus.comTectonic Therapeutic (NASDAQ:TECX) Shares Gap Up After Insider Buying ActivityTectonic Therapeutic (NASDAQ:TECX) Shares Gap Up After Insider Buying ActivityFebruary 10, 2025 | marketbeat.comTectonic Therapeutic director Timothy Springer buys $39.9 million in stockFebruary 8, 2025 | msn.comTectonic Therapeutic (NASDAQ:TECX) CFO Daniel Lochner Purchases 4,617 SharesFebruary 8, 2025 | insidertrades.comInsider Buying: Daniel Lochner Acquires Shares of Tectonic Therapeutic Inc (TECX)February 7, 2025 | gurufocus.comDaniel Lochner Buys 4,617 Shares of Tectonic Therapeutic (NASDAQ:TECX) StockTectonic Therapeutic (NASDAQ:TECX - Get Free Report) CFO Daniel Lochner bought 4,617 shares of the company's stock in a transaction that occurred on Wednesday, February 5th. The stock was purchased at an average price of $54.14 per share, with a total value of $249,964.38. Following the transaction, the chief financial officer now directly owns 4,617 shares in the company, valued at $249,964.38. The trade was a ∞ increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.February 7, 2025 | marketbeat.comTectonic Therapeutic (NASDAQ:TECX) Director Buys $6,999,977.16 in StockTectonic Therapeutic (NASDAQ:TECX - Get Free Report) Director Timothy A. Springer bought 129,294 shares of the company's stock in a transaction that occurred on Wednesday, February 5th. The shares were purchased at an average cost of $54.14 per share, for a total transaction of $6,999,977.16. Following the acquisition, the director now owns 4,226,058 shares of the company's stock, valued at $228,798,780.12. This represents a 3.16 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website.February 7, 2025 | marketbeat.comTectonic: Expansion Of TX45 Candidate Possible After Positive Interim DataFebruary 5, 2025 | seekingalpha.comTectonic Therapeutic (NASDAQ:TECX) Shares Down 3.2% - Time to Sell?Tectonic Therapeutic (NASDAQ:TECX) Stock Price Down 3.2% - Here's What HappenedFebruary 4, 2025 | marketbeat.comTectonic secures $185 million in private equity fundingFebruary 3, 2025 | msn.comTectonic announces ~$185M capital raiseFebruary 3, 2025 | msn.comTectonic Therapeutic announces $185M private placementFebruary 3, 2025 | markets.businessinsider.comTectonic Therapeutic, Inc. Announces $185 Million Private Investment in Public Equity FinancingFebruary 3, 2025 | quiverquant.comTectonic Announces $185 Million Private PlacementFebruary 3, 2025 | globenewswire.comTectonic Therapeutic (NASDAQ:TECX) Receives Consensus Rating of "Buy" from AnalystsShares of Tectonic Therapeutic (NASDAQ:TECX - Get Free Report) have earned a consensus rating of "Buy" from the six analysts that are presently covering the firm, Marketbeat reports. Five research analysts have rated the stock with a buy rating and one has given a strong buy rating to the companyFebruary 3, 2025 | marketbeat.comTectonic Therapeutic (NASDAQ:TECX) Stock Price Up 6.7% Following Analyst UpgradeTectonic Therapeutic (NASDAQ:TECX) Trading Up 6.7% Following Analyst UpgradeJanuary 31, 2025 | marketbeat.comTectonic Therapeutic (NASDAQ:TECX) Price Target Raised to $112.00Wells Fargo & Company upped their price objective on Tectonic Therapeutic from $79.00 to $112.00 and gave the company an "overweight" rating in a research note on Friday.January 31, 2025 | marketbeat.comTectonic Therapeutic (NASDAQ:TECX) Stock, Short Interest ReportJanuary 30, 2025 | benzinga.comTectonic Therapeutic Shares Hit 52-Week High After Positive Trial DataJanuary 30, 2025 | marketwatch.comPiper Sandler Reaffirms Their Buy Rating on Tectonic Therapeutic (TECX)January 30, 2025 | markets.businessinsider.comTectonic jumps on positive data from early-stage trial for lead assetJanuary 30, 2025 | msn.comTectonic Therapeutic (NASDAQ:TECX) Reaches New 1-Year High - Here's WhyTectonic Therapeutic (NASDAQ:TECX) Hits New 1-Year High - Still a Buy?January 30, 2025 | marketbeat.com Get Tectonic Therapeutic News Delivered to You Automatically Sign up to receive the latest news and ratings for TECX and its competitors with MarketBeat's FREE daily newsletter. Email Address TECX Media Mentions By Week TECX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TECX News Sentiment▼0.580.73▲Average Medical News Sentiment TECX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TECX Articles This Week▼123▲TECX Articles Average Week Get Tectonic Therapeutic News Delivered to You Automatically Sign up to receive the latest news and ratings for TECX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Ocular Therapeutix News Today Edgewise Therapeutics News Today Calliditas Therapeutics AB (publ) News Today Evotec News Today Amphastar Pharmaceuticals News Today Adaptive Biotechnologies News Today Iovance Biotherapeutics News Today Ardelyx News Today Structure Therapeutics News Today Aurinia Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TECX) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tectonic Therapeutic Please log in to your account or sign up in order to add this asset to your watchlist. Share Tectonic Therapeutic With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
